“Clinical and functional predictors that cause a decrease of indicators of morning blood pressure profile in antihypertensive telmisartan-based therapy” (2020) Biomedical Research and Therapy, 7(9), pp. 3985–3995. doi:10.15419/bmrat.v7i9.630.